Wanbury Ltd

NSE: WANBURY · BSE: 524212 · Pharmaceuticals & Biotechnology · 31 announcements

Wanbury Ltd news stories on ALFA NewsRead the news →

Share price: ₹201.31
Market cap: ₹703.9 Cr
Revenue (annual): ₹650.3 Cr
Net profit (annual): ₹66.13 Cr
P/E (TTM): 12.6×Sector 47.4×
Promoter holding: 43.02%+0.00% QoQ
FII holding: 0.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Business Update 4 Board Meeting Date 4 Management Change 3 Financial Results 3 Annual General Meeting 3 Share Pledge 2 Results Update 2 Product Launch 2 Debt & Borrowing 2 Price Movement Clarification 1 Merger & Restructuring 1 Legal & Regulatory 1 Employee Stock Options 1 Earnings Call 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

11 Aug 2026 21:07 IST NSE

Results Update

Wanbury Results Update

Wanbury reported Q1 FY27 financial results in a press release. The company also completed a Rs. 205 crore debt refinancing, improving its borrowing profile.

Value: ₹205.0 Cr

Read the filing ↗

2 Jun 2026 12:18 IST NSE

Results Update

Wanbury Results Update

Wanbury Limited reported ₹650.3 Crore revenue for FY26, with PAT surging 117% to ₹66.1 Crore. Strong growth was driven by new API launches and improved margins.

Value: ₹650.3 Cr

Read the filing ↗